Background: Clinical translation of immunohistochemistry (IHC) biomarkers requires reliable and reproducible cutoffs or thresholds for interpretation of immunostaining. Most IHC biomarker research focuses on the clinical relevance (diagnostic, prognostic, or predictive utility) of cutoffs, with less emphasis on observer agreement using these cutoffs. From the literature, we identified 3 commonly used cutoffs of 10% positive epithelial cells, 20% positive epithelial cells, and moderate to strong staining intensity (+2/+3 hereafter) to use for investigating observer agreement. Materials and Methods: A series of 36 images of microarray cores stained for 4 different IHC biomarkers, with variable staining intensity and percentage of positive ...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Authors: Oriol Arqués, Irene Chicote, Stephan Tenbaum, Isabel Puig & Héctor G. Palmer ### Abstract ...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
Background: Scoring of immunohistochemistry (IHC) staining is often done by non-pathologists, especi...
A b s t r a c t The effect of using a 30 % cutoff for the proportion of HER2+ cells on the interobse...
Background Immunohistochemistry (IHC) has become a valuable laboratory technique for diagnosing, ev...
Cancer diagnosis and personalized cancer treatment are heavily based on the visual assessment of imm...
Clinical immunohistochemistry (IHC) techniques are not yet fully standardized. In this project, a st...
Abstract Immunohistochemical (IHC) assays performed on formalin-fixed paraffin-embedded (FFPE) tissu...
Programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) is accepted as a predictive biomarker f...
Background. We conducted a validation study of digital pathology for the quantitative assessment of ...
Technical progress in immunohistochemistry (IHC) as well as the increased utility of IHC for biomark...
BackgroundThe data on the expression of stem cell markers CD44, CD24, and ALDH1A1 in the breast tiss...
Immunohistochemistry (IHC) is the group of techniques that use antibodies as specific reagents to id...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Authors: Oriol Arqués, Irene Chicote, Stephan Tenbaum, Isabel Puig & Héctor G. Palmer ### Abstract ...
AIM: Immunohistochemical analysis of protein expression is central to most clinical translational s...
Background: Scoring of immunohistochemistry (IHC) staining is often done by non-pathologists, especi...
A b s t r a c t The effect of using a 30 % cutoff for the proportion of HER2+ cells on the interobse...
Background Immunohistochemistry (IHC) has become a valuable laboratory technique for diagnosing, ev...
Cancer diagnosis and personalized cancer treatment are heavily based on the visual assessment of imm...
Clinical immunohistochemistry (IHC) techniques are not yet fully standardized. In this project, a st...
Abstract Immunohistochemical (IHC) assays performed on formalin-fixed paraffin-embedded (FFPE) tissu...
Programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) is accepted as a predictive biomarker f...
Background. We conducted a validation study of digital pathology for the quantitative assessment of ...
Technical progress in immunohistochemistry (IHC) as well as the increased utility of IHC for biomark...
BackgroundThe data on the expression of stem cell markers CD44, CD24, and ALDH1A1 in the breast tiss...
Immunohistochemistry (IHC) is the group of techniques that use antibodies as specific reagents to id...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
BackgroundIn breast cancer, immunohistochemical assessment of proliferation using the marker Ki67 ha...
Authors: Oriol Arqués, Irene Chicote, Stephan Tenbaum, Isabel Puig & Héctor G. Palmer ### Abstract ...